These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3294815)

  • 1. Management of behavioral symptoms in disturbed elderly patients: comparison of trifluoperazine and haloperidol.
    Lovett WC; Stokes DK; Taylor LB; Young ML; Free SM; Phelan DG
    J Clin Psychiatry; 1987 Jun; 48(6):234-6. PubMed ID: 3294815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of neuroleptics on behavioral symptoms in disturbed elderly patients.
    Ciccone PE
    J Clin Psychiatry; 1987 Dec; 48(12):497-8. PubMed ID: 3693339
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of hostile, suspicious patients. Trifluoperazine versus haloperidol.
    O'Brien CP; DiGiacomo JN; Webb W
    Dis Nerv Syst; 1974 Feb; 35(2):75-8. PubMed ID: 17894044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia.
    Götestam KG; Ljunghall S; Olsson B
    Acta Psychiatr Scand Suppl; 1981; 294():46-53. PubMed ID: 7041519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confirmed clinical efficacy of Actovegin in elderly patients with organic brain syndrome.
    Kanowski S; Kinzler E; Lehmann E; Schweizer A; Kuntz G
    Pharmacopsychiatry; 1995 Jul; 28(4):125-33. PubMed ID: 7491366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind study of thioridazine and haloperidol in geriatric patients with a psychosis associated with organic brain syndrome.
    Cowley LM; Glen RS
    J Clin Psychiatry; 1979 Oct; 40(10):411-9. PubMed ID: 489517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychopharmacological correlates of post-psychotic depression: a double-blind investigation of haloperidol vs thiothixene in outpatient schizophrenia.
    Abuzzahab FS; Zimmerman RL
    J Clin Psychiatry; 1982 Mar; 43(3):105-10. PubMed ID: 7037757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter study comparing thioridazine with diazepam and placebo in elderly, nonpsychotic patients with emotional and behavioral disorders.
    Stotsky B
    Clin Ther; 1984; 6(4):546-59. PubMed ID: 6380725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
    Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
    J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nylidrin HCL in the treatment of symptoms of the aged: a double-blind placebo controlled study.
    Goldstein SE; Birnbom F
    J Clin Psychiatry; 1979 Dec; 40(12):520-4. PubMed ID: 500575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.
    Petit M; Raniwalla J; Tweed J; Leutenegger E; Dollfus S; Kelly F
    Psychopharmacol Bull; 1996; 32(1):81-7. PubMed ID: 8927680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.
    Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol in controlling the symptoms of acute psychoses. II. A double-blind evaluation of haloperidol and trifluoperazine.
    Goldstein BJ; Clyde DJ
    Curr Ther Res Clin Exp; 1966 May; 8(5):236-40. PubMed ID: 4956549
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective short-term treatment of generalized anxiety disorder with trifluoperazine.
    Mendels J; Krajewski TF; Huffer V; Taylor RJ; Secunda S; Schless A; Sebastian JA; Semchyshyn G; Durr MJ; Melmed AS
    J Clin Psychiatry; 1986 Apr; 47(4):170-4. PubMed ID: 3514583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parenteral haloperidol in psychiatric emergencies. Double-blind comparison with chlorpromazine.
    Gerstenzang ML; Krulisky TV
    Dis Nerv Syst; 1977 Aug; 38(8):581-3. PubMed ID: 328243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial antipsychotic effects of allopurinol as add-on therapy for schizophrenia: a double blind, randomized and placebo controlled trial.
    Akhondzadeh S; Safarcherati A; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):253-9. PubMed ID: 15694232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.